Potential product interactions evaluation

If a consumer is exposed to hazardous product characteristics, the severity level or potential consequence of this exposure must be evaluated. Human factors analysis is conducted to determine the consequences (i.e., potential product-related injuries) based on the foreseeable behaviors consumers will use when interacting with products. Virtual and physical models of the human anatomy are used to effectively diagnose and demonstrate hazardous product characteristics. (In contrast to a physical hazard such as those noted above, physical in this human context relates to the usage of three-dimensional (3D) models of various parts of humans relevant to the exposures associated with use and/or misuse of a product.)... 

If the individual Tafel relations are known for the two or more pathways in the reaction, a general equation can be derived for the respective current efficiencies for the production of each of the products as a function of the electrode potential. However, interaction effects between the two processes, e.g., because of competitive adsorption among the reactant, intermediate, and product species, must usually be taken into account, making an a priori evaluation of current efficiencies difficult in all but the simplest cases. 

The choice of drilling fluid has a major impact on the evaluation and" production of a well. Later in this section, we will investigate the interaction between drilling fluids, logging operations and the potential damage to well productivity caused by mud invasion into the formation. 

The evaluation of the reaction cross sections as a function of the initial state of the reactants and final state of the products has been described by Karplus, Porter and Sharma (1965), and Greene and Kuppermann (1968) using classical equations of motions for interacting species. For a given potential V(rb r2, r3), a set of initial coordinates and momenta for the particles determine uniquely the collision trajectory and the occurrence of reaction. The method is described as follows. 

Several dosage forms carry an increased risk of degradation or adjunct formation. Products such as injections and aerosols are more likely to interact with volatiles or extractables from packaging and closure systems. Tablets have the potential to form adjuncts with excipients (specifically, lactose has been shown to form adjuncts in tablets). Non-CFC propellants in aerosols have a large number of impurities that typically do not interact with drug substances, but the potential for these interactions does still exist. Creams, ointments, lotions, and other such products will each have specific interactions that should be considered while evaluating the impurity profile of a drug product. 

Drug Interactions According to the product label, interactions between Intron A and other drugs have not been fully evaluated. Caution should be exercised when administering Intron A therapy in combination with other potentially myelo-suppressive agents such as zidovudine. Concomitant use of alfa interferon and theophylline decreases theophylline clearance, resulting in a 100% increase in serum theophylline levels. 

---